These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10599356)

  • 1. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): ECG exercise testing--three months follow-up.
    Biłan A; Chibowska M; Palusiński R; Witczak A; Ostrowski S; Makaruk B; Weglarz J; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():285-8. PubMed ID: 10599356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-up.
    Paulisiński R; Chibowska M; Biłan A; Ostrowski S; Weglarz J; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():295-8. PubMed ID: 10599358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): echocardiographic substudy--three months follow-up.
    Biłan A; Chibowska M; Makaruk B; Palusiński R; Weglarz J; Ostrowski S; Witczak A; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():279-83. PubMed ID: 10599355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment.
    Ostrowski S; Chibowska M; Biłan A; Palusiński R; Weglarz J; Makaruk B; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():289-93. PubMed ID: 10599357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction. The CONSENSUS II Holter Substudy Group.
    Søgaard P; Thygesen K
    Cardiology; 1997; 88(3):285-91. PubMed ID: 9129851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.
    Kaski JC; Rosano G; Gavrielides S; Chen L
    J Am Coll Cardiol; 1994 Mar; 23(3):652-7. PubMed ID: 8113548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of enalapril on exercise capacity and right ventricular function in patients with chronic cor pulmonale].
    Pérez-Calvo J; Civeira F; Ferrando J; Martínez-Rodés P; Torralba MA; Banzo J; Prats E; Bueno J
    An Med Interna; 2000 Oct; 17(10):527-32. PubMed ID: 11109647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P; Rietbrock N
    Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
    van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study.
    Di Marco F; Guazzi M; Vicenzi M; Santus P; Cazzola M; Pappalettera M; Castellotti P; Centanni S
    Pulm Pharmacol Ther; 2010 Jun; 23(3):159-64. PubMed ID: 20096799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.
    Silber JH; Cnaan A; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Cohen MI; Barber G; Rutkowski M; Kimball TR; Delaat C; Steinherz LJ; Zhao H
    J Clin Oncol; 2004 Mar; 22(5):820-8. PubMed ID: 14990637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
    Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
    Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of enalapril on basal arterial pressure at rest and during exercise and on cardiac performance in hypertensive athletes].
    D'Este D; Giada F; Sartori F; Noventa D; Cinquemani S; Mantovan R; Pascotto P
    G Ital Cardiol; 1990 Oct; 20(10):935-9. PubMed ID: 2090533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.